These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 11132219)

  • 1. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome.
    Morris CR; Kuypers FA; Larkin S; Vichinsky EP; Styles LA
    J Pediatr Hematol Oncol; 2000; 22(6):515-20. PubMed ID: 11132219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-arginine levels are diminished in adult acute vaso-occlusive sickle cell crisis in the emergency department.
    Lopez BL; Kreshak AA; Morris CR; Davis-Moon L; Ballas SK; Ma XL
    Br J Haematol; 2003 Feb; 120(3):532-4. PubMed ID: 12580975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana.
    Antwi-Boasiako C; Campbell AD
    Vasc Health Risk Manag; 2018; 14():199-204. PubMed ID: 30233199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
    Elshazly SA; Heiba NM; Abdelmageed WM
    Hematology; 2014 Jan; 19(1):52-9. PubMed ID: 23735470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease.
    Morris CR; Kuypers FA; Larkin S; Sweeters N; Simon J; Vichinsky EP; Styles LA
    Br J Haematol; 2000 Nov; 111(2):498-500. PubMed ID: 11122090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome.
    Yildirim N; Unal S; Yalcinkaya A; Karahan F; Oztas Y
    Ann Hematol; 2022 Jan; 101(1):35-41. PubMed ID: 34564750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state.
    Sins JWR; Schimmel M; Luken BM; Nur E; Zeerleder SS; van Tuijn CFJ; Brandjes DPM; Kopatz WF; Urbanus RT; Meijers JCM; Biemond BJ; Fijnvandraat K
    J Thromb Haemost; 2017 Jul; 15(7):1392-1402. PubMed ID: 28457019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study.
    Finkelstein Y; Schechter T; Garcia-Bournissen F; Kirby M; Nurmohamed L; Juurlink DN; Blanchette V; Koren G
    Clin Ther; 2007 Dec; 29(12):2738-43. PubMed ID: 18201591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterialization of venous blood for differentiation of sickle cell subjects in vaso-occlusive crisis.
    Nahavandi M; Tavakkoli F; Wyche MQ; Perlin E; Millis RM
    Hematology; 2003 Dec; 8(6):421-8. PubMed ID: 14668039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between plasma free haem and incidence of vaso-occlusive episodes and acute chest syndrome in children with sickle cell disease.
    Adisa OA; Hu Y; Ghosh S; Aryee D; Osunkwo I; Ofori-Acquah SF
    Br J Haematol; 2013 Sep; 162(5):702-5. PubMed ID: 23802701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.
    Bartolucci P; Habibi A; Khellaf M; Roudot-Thoraval F; Melica G; Lascaux AS; Moutereau S; Loric S; Wagner-Ballon O; Berkenou J; Santin A; Michel M; Renaud B; Lévy Y; Galactéros F; Godeau B
    EBioMedicine; 2016 Aug; 10():305-11. PubMed ID: 27412264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of acute pain crisis on exhaled nitric oxide levels in children with sickle cell disease.
    Pawar SS; Panepinto JA; Brousseau DC
    Pediatr Blood Cancer; 2008 Jan; 50(1):111-3. PubMed ID: 16619223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral arginine supplementation on exhaled nitric oxide concentration in sickle cell anemia and acute chest syndrome.
    Sullivan KJ; Kissoon N; Sandler E; Gauger C; Froyen M; Duckworth L; Brown M; Murphy S
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):e249-58. PubMed ID: 20724949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sickle cell acute chest syndrome: pathogenesis and rationale for treatment.
    Stuart MJ; Setty BN
    Blood; 1999 Sep; 94(5):1555-60. PubMed ID: 10477680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of lipid peroxidation and nitric oxide metabolites, trace elements, and antioxidant enzymes in patients with sickle cell disease.
    Antwi-Boasiako C; Dankwah GB; Aryee R; Hayfron-Benjamin C; Aboagye G; Campbell AD
    J Clin Lab Anal; 2020 Jul; 34(7):e23294. PubMed ID: 32170816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
    Buchanan ID; Woodward M; Reed GW
    Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial.
    Gladwin MT; Kato GJ; Weiner D; Onyekwere OC; Dampier C; Hsu L; Hagar RW; Howard T; Nuss R; Okam MM; Tremonti CK; Berman B; Villella A; Krishnamurti L; Lanzkron S; Castro O; Gordeuk VR; Coles WA; Peters-Lawrence M; Nichols J; Hall MK; Hildesheim M; Blackwelder WC; Baldassarre J; Casella JF;
    JAMA; 2011 Mar; 305(9):893-902. PubMed ID: 21364138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma sphingolipids in patients with sickle cell disease: Multiple-site vaso-occlusive crises could be associated with lower sphingolipid levels.
    Alp G; Oztas Y; Yalcinkaya A; Ozel S; Yildirim N; Unal S
    Lipids; 2024 May; 59(3):75-82. PubMed ID: 38332401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.
    Al Najjar S; Adam S; Ahmed N; Qari M
    Ann Hematol; 2017 Jan; 96(1):141-146. PubMed ID: 27686084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute chest syndrome among children hospitalized with vaso-occlusive crisis: A nationwide study in the United States.
    Takahashi T; Okubo Y; Handa A
    Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29134776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.